No CrossRef data available.
Article contents
Medical Comorbidity and Recovery in Individuals with Bipolar Disorder
Published online by Cambridge University Press: 07 November 2014
Extract
This discussion will focus on medical comorbidity and recovery in individuals with bipolar disorder. The complexity of care will be discussed in the context of a case study, with particular focus on the medical burden of mania, aging and bipolar disorder, and treatment approaches that promote functional recovery.
- Type
- Research Article
- Information
- CNS Spectrums , Volume 14 , Issue S15: Practical Management Strategies for Acute Mania and Mixed Episodes of Bipolar Disorder , December 2009 , pp. 16 - 19
- Copyright
- Copyright © Cambridge University Press 2009
References
1.Kilbourne, AM, Cornelius, JR, Han, X. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6(5):368–73.CrossRefGoogle ScholarPubMed
2.Fagiolini, A, Frank, E, Scott, JA, Turkin, S, Kupfer, DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 2005;7(5):424–430.CrossRefGoogle ScholarPubMed
3.Goff, D, Sullivan, LM, McEvoy, JP et al. , A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80(1):45–53.CrossRefGoogle ScholarPubMed
4.Cardenas, J, Frye, MA, Marusak, SL et al. , Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord. 2008;106(1–2):91–97.CrossRefGoogle ScholarPubMed
5.Chang, HH, Chou, CH, Chen, PS et al. , High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord. 2009;117(1–2):124–129.CrossRefGoogle ScholarPubMed
6.Correll, CU, Frederickson, AM, Kane, JM, Manu, P. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord. 2008;10(7):788–797.CrossRefGoogle ScholarPubMed
7.Elmslie, JL, Porter, RJ, Joyce, PR, Hunt, PJ, Shand, BI, Scott, RS. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls. Aust N Z J Psychiatry. 2009;43(1):53–60.CrossRefGoogle ScholarPubMed
8.Fagiolini, A, Frank, E, Turkin, S, Houck, PR, Soreca, I, Kupfer, DJ. Metabolic syndrome in patients with bipolar disorder. J Clin Psychiatry. 2008;69(4):678–679.CrossRefGoogle ScholarPubMed
9.Fiedorowicz, JG, Palagummi, NM, Forman-Hoffman, VL, Miller del, D, Haynes, WG. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry. 2008;20(3):131–137.CrossRefGoogle ScholarPubMed
10.Garcia-Portilla, MP, Saiz, PA, Benabarre, A et al. , The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord. 2008;106(1–2):197–201.CrossRefGoogle ScholarPubMed
11.John, AP, Koloth, R, Dragovic, M, Lim, SC. Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Aust. 2009;190(4):176–179.CrossRefGoogle ScholarPubMed
12.Salvi, V, Albert, U, Chiarle, A, Soreca, I, Bogetto, F, Maina, G. Metabolic syndrome in Italian patients with bipolar disorder. Gen Hosp Psychiatry. 2008;30(4):318–323.CrossRefGoogle ScholarPubMed
13.Sicras, A, Rejas, J, Navarro, R, Serrat, J, Blanca, M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord. 2008;10(5):607–616.CrossRefGoogle ScholarPubMed
14.van Winkel, R, De Hert, M, Van Eyck, D et al. , Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord. 2008;10(2):342–348.CrossRefGoogle Scholar
15.Vuksan-Cusa, B, Marcinko, D, Nad, S, Jakovljevic, M. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(1):109–112.CrossRefGoogle ScholarPubMed
16.Yumru, M, Savas, HA, Kurt, E et al. , Atypical antipsychotics related metabolic syndrome in bipolar patients. J Affect Disord. 2007;98(3):247–252.CrossRefGoogle ScholarPubMed
17.Kilbourne, AM, Post, EP, Nossek, A, Drill, L, Cooley, S, Bauer, MS. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. Psych Serv. 2008;59:760–768.CrossRefGoogle ScholarPubMed
18.Depp, CA, Jeste, DV. Bipolar disorder in older adults: a critical review. Bipolar Disord. 2004;6(5):343–367.CrossRefGoogle ScholarPubMed
19.Depp, CA, Lindamer, LA, Folsom, DP et al. , Differences in clinical features and mental health service use in bipolar disorder across the lifespan. Am J Geriatr Psychiatry. 2005;13(4):290–298.CrossRefGoogle ScholarPubMed
20.Ghose, K. The need for a review journal of drug use and the elderly. Drugs Aging. 1991;1(1):2–5.CrossRefGoogle ScholarPubMed
21.Burke, MJ, Preskorn, SH. Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice. Clin Pharmacokinet. 1999;37(2):147–165.CrossRefGoogle ScholarPubMed
22.ClinicalTrials.gov. Acute pharmacotherapy of late-life mania (GERI-BD). Available at: http://clinicaltrials.gov/ct2/show/NCT00254488?term=%22late+life+mania%22&rank=1. Accessed January 2009. International Congress on Bipolar Disorder (ISBD), June 25–28 2009, Pittsburgh, Pennsylvania.Google Scholar